Charles Schwab’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Charles Schwab’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-301,591	Closed	-$7.27M	–	3105
2014 Q2	$7.27M	Buy	301,591 +21,005	+7%	+$219K	0.01%	1095
2014 Q1	$1.69M	Sell	280,586 -7,153	-2%	-$49.9K	﹤0.01%	2040
2013 Q4	$1.72M	Buy	287,739 +32,375	+13%	+$150K	﹤0.01%	2007
2013 Q3	$1.28M	Buy	255,364 +5,823	+2%	+$25.5K	﹤0.01%	2085
2013 Q2	$896K	Buy	+249,541	New	+$1.02M	﹤0.01%	2223

Charles Schwab's IDIX Position: Q3 2014 in Review

Charles Schwab sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 301,591 shares — an estimated $7.27M sold.

Charles Schwab first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $7.27M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Charles Schwab reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Charles Schwab sold 301,591 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $7.27M.
Charles Schwab first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Charles Schwab's IDENIX PHARMACEUTICALS INC position peaked at $7.27M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Charles Schwab's 13F filing for Q3 2014, filed 10 Nov 2014.